Xia Yujing, Li Jingjing, Li Sainan, Liu Tong, Zhou Yuqing, Yin Qin, Wang Jianrong, Lu Wenxia, Zhang Rong, Zheng Yuanyuan, Wang Fan, Lu Jie, Chen Kan, Dai Weiqi, Zhou Yingqun, Guo Chuanyong
Department of Gastroenterology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, P.R. China.
Department of Gastroenterology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China.
Exp Ther Med. 2017 Nov;14(5):5228-5234. doi: 10.3892/etm.2017.5190. Epub 2017 Sep 22.
The aim of the present study was to explore the clinical value of urinary retinol-binding protein (RBP) level in the prognosis of cirrhotic ascites by assessment of the RBP levels prior to and following ascites treatment. The levels of urinary RBP, urinary microalbumin (mAlb), serum urea nitrogen (urea) and serum creatinine (Cr), and the estimated glomerular filtration rate (eGFR) were measured in 90 patients with cirrhosis and ascites hospitalized in a single institution between May 2011 and January 2012, and in 30 healthy controls. The levels of urinary mAlb, serum urea and serum Cr were higher in the cirrhotic patients compared with the healthy controls (P<0.05). Urinary RBP levels were significantly higher and eGFR was significantly lower in the liver cirrhosis group compared with the healthy control group (P<0.01). Urinary RBP, urinary mAlb, serum urea and serum Cr increased and eGFR decreased as the severity of the ascites increased (P<0.05). Urinary RBP was significantly higher in patients whose ascites did not respond or was refractory compared with those in whom it subsided (P<0.05), exhibiting a gradual increase over time in the former and a gradual reduction over time in the latter group (P<0.05). Increased urinary RBP and decreased eGFR in the early stage of cirrhosis ascites suggested impaired renal function, which serves a role in the process of ascites formation. These results indicated that urinary RBP is a sensitive indicator of early renal injury in patients with ascites due to cirrhosis and is closely associated with the progression of cirrhotic ascites.
本研究旨在通过评估腹水治疗前后视黄醇结合蛋白(RBP)水平,探讨尿RBP水平在肝硬化腹水预后中的临床价值。对2011年5月至2012年1月在某单一机构住院的90例肝硬化腹水患者及30例健康对照者,检测其尿RBP、尿微量白蛋白(mAlb)、血清尿素氮(尿素)、血清肌酐(Cr)水平及估计肾小球滤过率(eGFR)。肝硬化患者尿mAlb、血清尿素和血清Cr水平高于健康对照者(P<0.05)。肝硬化组尿RBP水平显著高于健康对照组,eGFR显著低于健康对照组(P<0.01)。随着腹水严重程度增加,尿RBP、尿mAlb、血清尿素和血清Cr升高,eGFR降低(P<0.05)。腹水无反应或难治的患者尿RBP显著高于腹水消退的患者(P<0.05),前者随时间逐渐升高,后者随时间逐渐降低(P<0.05)。肝硬化腹水早期尿RBP升高、eGFR降低提示肾功能受损,在腹水形成过程中起作用。这些结果表明,尿RBP是肝硬化腹水患者早期肾损伤的敏感指标,与肝硬化腹水的进展密切相关。